This $387,880 federal project grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports research on telehealth-delivered buprenorphine treatment to improve post-incarceration engagement for individuals with opioid use disorder (OUD) who have criminal-legal involvement (CLI).
The key objectives are to: 1) identify predictors of post-release buprenorphine treatment linkage, 2) examine stakeholder perspectives to inform a tele-buprenorphine protocol for low-threshold treatment linkage, and 3) conduct a pilot randomized controlled trial on the feasibility and acceptability of a tele-buprenorphine intervention for OUD treatment after jail release. This research aims to develop an evidence-based telehealth approach to address structural barriers to OUD treatment engagement and overdose risk for this marginalized population. The 5-year award period runs from May 1, 2024 to April 30, 2029 and will be conducted by the Icahn School of Medicine at Mount Sinai, a renowned academic medical center in New York.
Generated 3/4/25, 5:37 AM